WORCESTER, N.Y., Aug. 8, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (http://www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, commented today on recent trading activity in its common stock. The Company knows of no reason for the recent decline in the price of its stock.
